A Study of Inhaled Atropine Sulfate in Healthy Adults
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This
pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by
the ADPI to atropine delivery from the AtroPen autoinjector.
Phase:
Phase 1
Details
Lead Sponsor:
MicroDose Defense Products L.L.C.
Collaborators:
U.S. Army Space and Missile Defense Command University of Pittsburgh